Tu1483 - Hepatic Safety and Biomarker Assessments in Sorafenibexperienced Patients with Advanced Hepatocellular Carcinoma Treated with Nivolumab in the Checkmate-040 Study — Todd S. Crocenzi (2018) | RDL Network
Tu1483 - Hepatic Safety and Biomarker Assessments in Sorafenibexperienced Patients with Advanced Hepatocellular Carcinoma Treated with Nivolumab in the Checkmate-040 Study
Ignacio Melero, Bruno Sangro, Thomas Cheung Yau, Chiun Hsu, Masatoshi Kudo, Todd S. Crocenzi, Tae‐You Kim, Su Pin Choo, Jörg Trojan, Tim Meyer, Theodore H. Welling, Winnie Yeo, Akhil Chopra, Jeffrey Anderson, Christine Marie Dela Cruz, Lixin Lang, Jaclyn Neely, Hao Tang, Anthony B. El-Khoueiry
Bruno Sangro, Ana Matilla, Armando Santoro, Ignacio Melero, Antonio Cubillo Gracián, Mirelis Rivera Acosta, Su Pin Choo, Anthony El-Khoureiry, Ryoko Kuromatsu, Bassel F. El‐Rayes, Kazushi Numata, Yoshito Itoh, Francesco Di Costanzo, Oxana Crysler, María Reig, Yun Shen, Jaclyn Neely, Christine Dela Cruz, Carlos Baccan, Masatoshi Kudo
Thomas Yau, Chih‐Hung Hsu, Yoon‐Koo Kang, T. Kim, Ming‐Mo Hou, Ho Yeong Lim, Yee Chao, Y. Kim, Masafumi Ikeda, Su Pin Choo, Jaclyn Neely, Yun Shen, Marina Tschaika, Masatoshi Kudo
Discussion(0)
No comments yet. Be the first to comment.